
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A prominent research institution in Singapore is seeking an experienced clinical monitor to oversee study sites for clinical research in infectious diseases. The role involves conducting site visits, ensuring compliance with study protocols, and maintaining data integrity. Ideal candidates will have a degree in a relevant field and substantial experience in clinical monitoring. Strong communication and organizational skills are essential for success in this role.
Interested applicants are invited to apply directly at the NUS Career Portal
Your application will be processed only if you apply via the NUS Career Portal
We regret that only shortlisted candidates will be notified.
We are looking for an experienced clinical monitor to perform the study monitoring in ADVANcing Clinical Evidence in Infectious Diseases Network (ADVANCE ID).
ADVANCE ID is jointly funded by the Wellcome Trust and Singapore institutions including the Saw Swee Hock School of Public Health and Yong Loo Lin School of Medicine, National University of Singapore. The vision of the Network is to improve public health by developing the clinical evidence base for the prevention and treatment of drug‑resistant infections. Its mission is to build and sustain a strategic clinical research network focussed on most efficiently delivering locally relevant interventions for drug‑resistant infections.
The Network aims to improve and strengthen clinical research capabilities in the region by acting as a platform to develop good principles and practices. It will stabilise capacity and capabilities to mitigate inefficiencies in trial start‑up phase and loss of skillset following study closure, as in typical trial setup. The Network will continuously develop its capabilities, quality and efficiency by learning from and collaborating with other clinical trial networks.
In the long term, the Network aims to support broader infectious disease studies by expanding geographically beyond its original starting point in South East Asia and collaborating with other networks around the world. It will function as an active network that involves patients in platform trials, allowing for rapid clinical research response in the event of an emerging infectious disease or pandemic threat. The monitor should be able to supervise study sites and activities to ensure adherence to appropriate study protocols and applicable regulatory requirement terms of the study.